Lung adenocarcinoma is more likely to develop in women and those without a history of smoking, in which some targetable gene mutations including growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), BRAF, and ROS1 were positively expressed [5–8]. This evidence concerns the gene ALK and lung adenocarcinoma.